Employment Support After Hematopoietic Stem Cell Transplantation

Recruiting now · Not applicable

Conditions studied: Hematopoietic Stem Cell Transplantation

In brief

This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The aim of this study is to evaluate "proof of concept" by: 1. examining the feasibility and acceptability of the WorkS intervention and the study procedures, and 2. exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy, work status, quality of life, and financial toxicity.

Key facts

Study ID

NCT06494423

Run by

MGH Institute of Health Professions

People needed

35

Starts

2024-07-31

Expected to finish

2027-12-31

Last updated by the study team

2025-12-19

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Received an allogeneic HSCT within the past six months to treat a hematological malignancy.
• Screen positive for work-related concerns (i.e., responds "yes" to the question, "Are you concerned about your ability to return to work in the coming six months?")

You may not qualify if…

• Patients with acute psychiatric or cognitive conditions which the treating clinician believes prohibits informed consent or compliance with the study procedures
• We will not enroll the following special populations: adults unable to consent, individuals not yet adults, pregnant women, and prisoners.

Where it is running

• MGH Cancer Center — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.